EDAP TMS SA 8-K

What Happened

• EDAP TMS S.A. filed an 8-K reporting that director Glen French resigned from the Board and from the audit, compensation and nominations committees, effective immediately on February 10, 2026. The resignation was not due to any dispute or disagreement with the Company or the Board.
• On February 11, 2026 the Company appointed David Horn (age 58) to the Board, effective immediately, to fill the vacancy. Mr. Horn will serve on the audit and nominations committees. His appointment will be submitted for shareholder approval at the next convened annual Ordinary and Extraordinary General Meeting. The Company issued a press release on February 12, 2026 announcing these changes.

Key Details

• Resignation date: February 10, 2026 (Glen French); Appointment date: February 11, 2026 (David Horn).
• Mr. Horn roles: President & CFO of Seer, Inc. since 2023; joined Seer as CFO in 2020; >20 years at Morgan Stanley in healthcare investment banking; prior roles in medical device and life sciences companies.
• Committee assignments: Mr. Horn will join the audit and nominations committees.
• Governance notes: Mr. Horn has no family ties to current directors/officers, no reportable related-party transactions under Item 404(a), and will be paid under the Company’s standard director compensation policy.

Why It Matters

• Board composition and audit committee membership affect corporate oversight of finance and controls; adding an experienced finance executive with healthcare/life-sciences background may influence investor confidence in financial governance and strategic oversight.
• The appointment is effective immediately but will be subject to shareholder approval at the next general meeting, so investors should watch for confirmation at that meeting and any related proxy disclosures.